People: DarioHealth Corp (DRIO.OQ)

DRIO.OQ on NASDAQ Stock Exchange Capital Market

25 Sep 2020
Change (% chg)

$0.70 (+4.44%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Karah, Hila 

Ms. Hila Karah serves as Independent Director of the Company. Ms. Karah is an independent business consultant and an investor in several high-tech, biotech and internet companies. From 2006 to 2013, she served as a partner and Chief Investment Officer of Eurotrust Ltd., a family office. From 2002 to 2005, she served as a research analyst at Perceptive Life Sciences Ltd., a New York-based hedge fund. Prior to that, Ms. Karah served as research analyst at Oracle Partners Ltd., a health care-focused hedge fund. Ms. Karah has served as a director in several private and public companies including Intec Pharma, since 2009 and Cyren Ltd since 2008. We believe Ms. Karah is qualified to serve on our Board of Directors because of her experience as an investor in and advisor to high-tech, biotech and internet companies. Ms. Karah holds a B.A. in Molecular and Cell Biology from the University of California, Berkeley, and studied at the University of California, Berkeley-University of California, San Francisco Joint Medical Program.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 41,000
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 41,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Yoav Shaked


Richard Anderson


Erez Raphael


Zvi Ben-David


Dror Bacher


Olivier Jarry

As Of  31 Dec 2019